Premium
Obovatol Induces Apoptosis in Non‐small Cell Lung Cancer Cells via C/EBP Homologous Protein Activation
Author(s) -
Kim Heejeong,
Shin Eun Ah,
Kim Chang Geun,
Lee Dae Young,
Kim Bonglee,
Baek NamIn,
Kim SungHoon
Publication year - 2016
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.5690
Subject(s) - a549 cell , chop , apoptosis , unfolded protein response , cancer research , endoplasmic reticulum , microbiology and biotechnology , cell , programmed cell death , cancer cell , biology , chemistry , cancer , biochemistry , genetics
Although obovatol, a phenolic compound from the bark of Magnolia obovata , was known to have antioxidant, neuroprotective, antiinflammatory, antithrombotic and antitumour effects, its underlying antitumour mechanism is poorly understood so far. Thus, in the present study, the antitumour molecular mechanism of obovatol was investigated in non‐small cell lung cancer cells (NSCLCs). Obovatol exerted cytotoxicity in A549 and H460 NSCLCs, but not in BEAS‐2B cells. Also, obovatol increased sub‐G1 accumulation and early and late apoptotic portion in A549 and H460 NSCLCs. Consistently, obovatol cleaved PARP, activated caspase 9/3 and Bax and attenuated the expression of cyclin D1 in A549 and H460 NSCLCs. Interestingly, obovatol upregulated the expression of endoplasmic reticulum stress proteins such as C/EBP homologous protein (CHOP), IRE1α, ATF4 and p‐elF2 in A549 and H460 NSCLCs. Conversely, depletion of CHOP blocked the apoptotic activity of obovatol to increase sub‐G1 accumulation in A549 and H460 NSCLCs. Overall, our findings support scientific evidences that obovatol induces apoptosis via CHOP activation in A549 and H460 NSCLCs. Copyright © 2016 John Wiley & Sons, Ltd.